Skip to main content
UFinityRegister

Payments & AR

Clinical Research Patient Billing Software

Statements that bill participants only for routine care they owe, keep sponsor-paid study work off the page and hold the bill while coverage is still under review.

Clinical Research Patient Billing Software sends trial participants statements for only what they owe: deductibles, copays and coinsurance on routine care. Anything the sponsor pays for stays off the statement. Bills wait while the study team confirms coverage, and each statement shows plainly which visit it covers, so a participant can trust it.

Get a Demo
★★★★★4.8/5G2★★★★★5/5Gartner4.4/5GetApp★★★★★5/5
6,500+ specialty providersSOC 2 certified
Team working through claims documents and reports at a desk
Unlimited Financials payment posting & denial management software interface

Patient Billing in a Clinical Research Practice

A participant's visit may hold a routine office visit, a study-only lab, a research ECG and a scan the coverage analysis splits between payers. Only the routine items that insurance actually paid, and the share the plan left to the patient, belong on a statement. Unlimited Systems builds the statement from the posted claim, not from the raw charges, so sponsor-paid lines never show up as a balance. While a visit's charges are still in research billing review, the statement for that visit is held, and the hold carries a reason. For Original Medicare patients, Q1 lines carry the usual deductible and coinsurance. Medicare Advantage patients in a qualifying trial are billed under Original Medicare, and the plan later pays the patient back the cost-sharing gap, so their statement is written to double as proof for that claim. Payment options on each statement come from the same ledger the billing team uses.

Why Is Patient Billing Different in Clinical Research?

Trust is the whole point of patient billing in research. A participant who gets a bill for a study-only blood draw may stop coming to visits, or tell the coordinator the trial costs money. That can cost the site the participant and the sponsor a data point. Statements at a research site have to be right the first time, because a wrong one does more harm than a late one.

The balance itself is harder to know. A routine scan at a study visit may be billed to insurance while the extra slice the protocol asks for is billed to the sponsor. Until both are settled, the patient's real share isn't known. Sending a statement from charges before the claim pays risks billing the patient for a line the sponsor will cover. Patient billing here has to wait for the remittance and read it.

Medicare Advantage adds a step most practices never see. For qualifying trials, routine costs for these patients are billed to Original Medicare, which means Original Medicare cost sharing. The plan must then pay the enrollee the difference between that and its own in-network cost sharing, and it may ask for proof such as a provider bill. A clear statement that names the trial service helps the patient get that money back.

What Clinical Research Patient Billing Software Handles

Sponsor-provided items
Medicare's trial policy does not cover items and services that sponsors customarily provide free to every enrollee. Those lines are routed to the sponsor budget and never reach a patient statement. (CMS National Coverage Determination 310.1: Routine Costs in Clinical Trials)
Non-covered lines with no patient liability
When a free sponsor item must appear on a Medicare claim, CMS says to bill it as non-covered while making sure the patient is not held liable. Those lines are blocked from the statement. (CMS Medicare Claims Processing Manual, Chapter 32, Section 69: Qualifying Clinical Trials)
Q1 coinsurance for Original Medicare
Routine trial services billed with Q1 follow normal deductible and coinsurance rules for Original Medicare patients. That share flows to a supplemental payer or the statement like any other balance. (CMS Medicare Claims Processing Manual, Chapter 32, Section 69: Qualifying Clinical Trials)
Medicare Advantage cost-sharing gap
The plan owes the enrollee the difference between Original Medicare cost sharing and its own in-network cost sharing. Enrollees may need to show a provider bill, so the statement names the trial service and its date. (CMS Medicare Managed Care Manual, Chapter 4, Section 10.7.1: Payment for Services in Clinical Trials)
Investigational drug charges
A sponsor needs prior written FDA authorization before it may charge for an investigational drug, and may recover only direct costs. A study-drug line headed for a participant's statement is stopped for review. (21 CFR 312.8: Charging for investigational drugs under an IND)
Participant stipends
FDA guidance treats payment to research subjects as a matter for the IRB, which reviews the amount, method and timing. Stipends are paid through the study's own process and are not netted against a patient balance. (FDA guidance: Payment and Reimbursement to Research Subjects)

How Does Clinical Research Patient Billing Software Work?

  1. 1. Hold statements during research review

    A visit whose charges are still being checked against the coverage analysis gets a statement hold with a reason. The hold lifts when the review is done and the claim is out.

  2. 2. Build the balance from the remittance

    The patient share comes from what insurance actually paid and assigned to the patient. Sponsor-paid and non-covered sponsor lines are excluded, so they never turn into a balance.

  3. 3. Write statements that name the visit

    Each statement shows the visit date, the routine service and what insurance paid. Participants can match it to their study calendar, and Medicare Advantage patients can send it to their plan.

  4. 4. Check estimates against actuals

    Estimates made during financial clearance leave sponsor-paid items out. When the claim pays, the real share is compared with the estimate, and big gaps go to staff before the statement is sent.

  5. 5. Offer the right way to pay

    Statements link to the portal, card on file and payment plans described under integrated patient payments. Every payment posts to the same ledger the billing team works from.

Clinical Research Patient Billing Software vs. Generic Software

AreaGeneric approachUnlimited Systems
Statement timingStatements sent from charges before the claim pays.Statements built from the posted remittance, after research review.
Sponsor-paid linesAppear on the bill and get written off after a call.Excluded before the statement is built.
Medicare Advantage patientsBilled with no note about the plan's cost-sharing refund.Statement names the trial service so the patient can claim the gap.
Study drugBilled if it came through on the charge feed.Held for review, since charging needs FDA authorization.
StipendsSometimes offset against balances.Kept separate, paid through the study's own process.

Who Uses It in a Clinical Research Practice

  • Billing specialist: Statements built from paid claims, with sponsor lines already split off during research charge review and held visits listed with their reason.
  • Research coordinator: Fewer upset calls from participants, and a statement they can walk through with a patient line by line.
  • Practice manager: Confidence that participants are billed only for routine care they owe, with holds and estimates tracked by study.
Knowledge base

Clinical Research Patient Billing Software FAQs

Patient billing builds each statement from the posted claim rather than from raw charges. Lines the coverage analysis assigns to the sponsor never go to insurance and never become a patient balance. Sponsor items that must appear on a Medicare claim are billed as non-covered with no patient liability. What is left on the statement is the deductible, copay or coinsurance on routine care.

Related Clinical Research Software

Sources

  1. CMS National Coverage Determination 310.1: Routine Costs in Clinical Trials
  2. CMS Medicare Claims Processing Manual, Chapter 32, Section 69: Qualifying Clinical Trials
  3. CMS Medicare Managed Care Manual, Chapter 4, Section 10.7.1: Payment for Services in Clinical Trials
  4. 21 CFR 312.8: Charging for investigational drugs under an IND
  5. FDA guidance: Payment and Reimbursement to Research Subjects

GET STARTED

See Unlimited Systems in Action

Whether you're actively evaluating new technology or simply preparing for your next vendor renewal, Unlimited Systems can help you understand where your current workflows may be creating avoidable revenue risk.

★★★★★4.8/5G2★★★★★5/5Gartner4.4/5GetApp★★★★★5/5
6,500+ specialty providersSOC 2 certified